Prosecution Insights
Last updated: October 27, 2026

Kristen Wang Romero, USPTO Patent Examiner

Listed by the USPTO as ROMERO, KRISTEN WANG

Tech Center 1600 • Art Units: 1624 1625 1626 1629

This examiner grants 70% of resolved cases

Analysis

ROMERO, KRISTEN WANG is assigned to tech center 1600 and art unit 1624. The profile shows 53 resolved cases, a 69.8% allowance rate, and a median of 1161 days to allowance. The 30.8% interview lift indicates a substantial positive association between interviews and allowance outcomes, although the case history is limited.

The listed companies are Shanghai Apeiron Therapeutics Company Limited, THE GENERAL HOSPITAL Corporation, and Vanderbilt University. The listed firms are OLIFF PLC, ARENTFOX SCHIFF LLP, and BakerHostetler. Practitioners should account for the available but limited record when assessing the allowance pattern, and can consider interviews as a meaningful tool during extended prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

69.8%
Allow Rate
+9.8% vs TC avg
89
Total Applications
+30.8%
Interview Lift
1161
Avg Prosecution Days
Based on 53 resolved cases, 2023–2026

Rejection Statute Breakdown

4.0%
§101 Eligibility
19.9%
§102 Novelty
20.3%
§103 Obviousness
39.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18263384 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Non-Final OA The General Hospital Corporation
17932466 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME Non-Final OA VANDERBILT UNIVERSITY
18605320 Compositions of Azadirachta Indica and Methods of Treating Cancer Non-Final OA Board of Regents, The University of Texas System
18768262 COMPOUNDS FOR THE TREATMENT OF GLYCOGEN STORAGE DISORDERS Non-Final OA RAMOT AT TEL-AVIV UNIVERSITY LTD.
18549638 TRICYCLIC PYRIMIDINES AS CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS Non-Final OA JANSSEN PHARMACEUTICA NV

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Kristen Wang Romero's allowance rate?

69.8% of resolved applications examined by Kristen Wang Romero were allowed (53 resolved cases), compared with 54.6% across Art Unit 1624 over the last five years.

Does an interview help with examiner Kristen Wang Romero?

This examiner's interview lift is +30.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Kristen Wang Romero take to allow a patent?

Applications allowed by Kristen Wang Romero took 1,161 days on average from filing to allowance.

Which art unit does examiner Kristen Wang Romero work in?

Kristen Wang Romero examines applications in Art Unit 1624 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month